Contact Us
Search Icon
Article 54 Understanding the Clinical Evaluation Consultation Process
  • Webinar
    Medical Devices

Article 54 Understanding the Clinical Evaluation Consultation Process

This webinar will provide the required information to manufacturers in accordance with Article 54 of the Medical Device Regulations EU 2017/745.

In this Webinar:

  • Article 54 (1) outlines the classifications of devices that are potential subject to CECP.

  • What triggers CECP for a legacy device.

  • The CECP process - considerations of submitted documentation.

  • Article 54.3 & Article 61 (2).

Class III implantable, class IIb active rule 12 administer or ARMS devices

Information to manufacturers of class III implantable, and class IIb active rule 12 administer or remove medicinal substances (ARMS) devices.

  • Richard Holborow, Head of Clinical Compliance, BSI

  • Sheila Walsh, Clinical Regulatory Lead, Clinical Compliance Team, BSI

Contact Us

Let's shape your organization's future together

Reach out and see how we can help guide you on your path to sustainable operational success.

Get in touch